Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Gertz

Showing results (11-20 of 242) with videos related to

Pageof 25
Sort By:
Seminars in Hematology|January 1, 1995
Primary systemic amyloidosis: clinical and laboratory features in 474 casesR A Kyle, M A Gertz
Chest|December 1, 1986
Clinical aspects of pulmonary amyloidosisM A Gertz, P R Greipp
Journal of Intensive Care Medicine|April 8, 1995
Hyperviscosity syndromeM A Gertz, R A Kyle
American Journal of Hematology|May 1, 1990
Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosisM A Gertz, R A Kyle
Mayo Clinic Proceedings|December 1, 1989
Primary systemic amyloidosis--a diagnostic primerM A Gertz, R A Kyle
Hepatology (Baltimore, Md.)|January 1, 1997
Hepatic amyloidosis: clinical appraisal in 77 patientsM A Gertz, R A Kyle
Mayo Clinic Proceedings|March 1, 1986
Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literatureM A Gertz, R A Kyle
American Journal of Clinical Pathology|September 1, 1990
Prognostic value of urinary protein in primary systemic amyloidosis (AL)M A Gertz, R A Kyle
American Journal of Hematology|October 1, 1993
Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosisM A Gertz, R A Kyle
Hematology/Oncology Clinics of North America|January 8, 2000
Acquired Fanconi's syndrome associated with monoclonal gammopathiesM Q Lacy, M A Gertz
Pageof 25

Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Seminars in Hematology|January 1, 1995
Primary systemic amyloidosis: clinical and laboratory features in 474 casesR A Kyle, M A Gertz
Chest|December 1, 1986
Clinical aspects of pulmonary amyloidosisM A Gertz, P R Greipp
Journal of Intensive Care Medicine|April 8, 1995
Hyperviscosity syndromeM A Gertz, R A Kyle
American Journal of Hematology|May 1, 1990
Phase II trial of alpha-tocopherol (vitamin E) in the treatment of primary systemic amyloidosisM A Gertz, R A Kyle
Mayo Clinic Proceedings|December 1, 1989
Primary systemic amyloidosis--a diagnostic primerM A Gertz, R A Kyle
Hepatology (Baltimore, Md.)|January 1, 1997
Hepatic amyloidosis: clinical appraisal in 77 patientsM A Gertz, R A Kyle
Mayo Clinic Proceedings|March 1, 1986
Response of primary hepatic amyloidosis to melphalan and prednisone: a case report and review of the literatureM A Gertz, R A Kyle
American Journal of Clinical Pathology|September 1, 1990
Prognostic value of urinary protein in primary systemic amyloidosis (AL)M A Gertz, R A Kyle
American Journal of Hematology|October 1, 1993
Phase II trial of recombinant interferon alfa-2 in the treatment of primary systemic amyloidosisM A Gertz, R A Kyle
Hematology/Oncology Clinics of North America|January 8, 2000
Acquired Fanconi's syndrome associated with monoclonal gammopathiesM Q Lacy, M A Gertz
Pageof 25